Acadia Healthcare Company, Inc. current report, 30 December 2011

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report (Form 8-K) covers the period ending December 30, 2011, with a filing date of January 5, 2012. The report details a material definitive agreement entered into by Acadia Healthcare Company, Inc. ("Acadia") and its wholly-owned subsidiary, Hermitage Behavioral, LLC.

Key Financial Metrics and Transaction Details

  • Transaction Type: Acquisition of membership interests in two subsidiaries of Haven Behavioral Healthcare Holdings, LLC.
  • Assets Acquired: Three behavioral healthcare facilities owned, operated, and managed by the target subsidiaries.
  • Purchase Price: $91.0 million.
  • Escrow Amount: $5.0 million to be held until April 30, 2013, for potential indemnification claims.
  • Funding Sources: Net proceeds from a December 2011 equity offering and a partial draw on Acadia's revolving line of credit.
  • Expected Closing: First quarter of 2012.

The filing text does not provide specific values for revenue, profit, cash flow, margins, or total debt levels for the reporting period, as this document focuses on the acquisition agreement rather than periodic financial results.

Material Changes and Conditions

The primary material change is the entry into the Membership Interest Purchase Agreement. The transaction is subject to several conditions, including:

  • Expiration or termination of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
  • Receipt of material governmental and third-party consents and approvals.
  • Other customary closing conditions.

The agreement includes a termination right for either party if the closing does not occur on or before April 1, 2012, subject to certain conditions.

Outlook, Risks, and Management Commentary

Management expects to close the transaction in the first quarter of 2012. The filing notes that the summary is subject to the full text of the Purchase Agreement attached as Exhibit 2. Risks associated with the transaction include the failure to obtain necessary regulatory approvals or the inability to meet the closing deadline, which could result in termination of the agreement.

Key Facts for Investor Verification

  • Verify the status of regulatory approvals required under the Hart-Scott-Rodino Act and other governmental bodies.
  • Confirm the actual closing date and whether the transaction proceeds as scheduled in Q1 2012.
  • Review the full text of the Membership Interest Purchase Agreement (Exhibit 2) for specific representations, warranties, and indemnity terms.
  • Monitor the impact of the $91.0 million purchase price and the $5.0 million escrow on Acadia's liquidity and debt covenants.